These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3666987)

  • 61. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
    Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
    Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinicopathological evaluation of preoperative chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel for locally advanced breast cancer].
    Miyake T; Miyahara S; Fujii K; Taniguchi M; Yamamura K; Tadokoro K; Tanimura M; Nakamura H
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):401-5. PubMed ID: 19295263
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
    Ung O; Langlands AO; Barraclough B; Boyages J
    J Clin Oncol; 1995 Feb; 13(2):435-43. PubMed ID: 7844606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
    Hortobagyi GN; Buzdar AU; Theriault RL; Valero V; Frye D; Booser DJ; Holmes FA; Giralt S; Khouri I; Andersson B; Gajewski JL; Rondon G; Smith TL; Singletary SE; Ames FC; Sneige N; Strom EA; McNeese MD; Deisseroth AB; Champlin RE
    J Natl Cancer Inst; 2000 Feb; 92(3):225-33. PubMed ID: 10655439
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].
    Arce-Salinas C; Lara-Medina FU; Alvarado-Miranda A; Castañeda-Soto N; Bargalló-Rocha E; Ramírez-Ugalde MT; Pérez-Sánchez V; Rivera L; Gambo-Vignole C; Santamaría-Galicia J; Nieves-Casas RI; Morán-Muñoz H; Mohar-Betancourt A
    Rev Invest Clin; 2012; 64(1):9-16. PubMed ID: 22690524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
    Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate MI; Ferranti FR; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
    Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
    Blumenschein GR; DiStefano A; Caderao J; Fristenberg B; Adams J; Schweichler LH; Drinkard L
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2633-7. PubMed ID: 10068266
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of short-term cyclophosphamide on estrogen therapy in metastatic breast cancer.
    Kennedy BJ; Kiang DT
    Med Pediatr Oncol; 1975; 1(3):265-70. PubMed ID: 1232533
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results.
    Conte PF; Gardin G; Pronzato P; Miglietta L; Rosso R; Amadori D; Gentilini P; Monzeglio C; Gallotti P; Demicheli R
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1103-8. PubMed ID: 1981014
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: preliminary results of a double-blind randomized study of the EORTC Breast Cancer Cooperative Group.
    Paridaens R; Heuson JC; Julien JP; Veyret C; van Zijl J; Klijn JG; Sylvester RJ; Mignolet F
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1109-13. PubMed ID: 2285584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of DES vs DES + chlorambucil in women with first recurrence of breast cancer.
    Holzer D; Harvey HA; Lipton A
    J Surg Oncol; 1979; 12(1):1-9. PubMed ID: 480949
    [TBL] [Abstract][Full Text] [Related]  

  • 73. When and how do I use neoadjuvant chemotherapy for breast cancer?
    Rapoport BL; Demetriou GS; Moodley SD; Benn CA
    Curr Treat Options Oncol; 2014 Mar; 15(1):86-98. PubMed ID: 24306808
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients.
    Chevallier B; Bastit P; Graic Y; Menard JF; Dauce JP; Julien JP; Clavier B; Kunlin A; D'Anjou J
    Br J Cancer; 1993 Mar; 67(3):594-601. PubMed ID: 8439510
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management of locally advanced breast cancer.
    Borgen PI
    World J Surg; 1994; 18(1):81-6. PubMed ID: 8197781
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer.
    Gardin G; Alama A; Rosso R; Campora E; Repetto L; Pronzato P; Merlini L; Naso C; Camoriano A; Meazza R
    Breast Cancer Res Treat; 1994; 32(3):311-8. PubMed ID: 7865857
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro sensitivity testing of human breast cancer cells to hormones and chemotherapeutic agents.
    Emerman JT; Tolcher AW; Rebbeck PM
    Cancer Chemother Pharmacol; 1990; 26(4):245-9. PubMed ID: 2164456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic results.
    Conte PF; Alama A; Bertelli G; Canavese G; Carnino F; Catturich A; Di Marco E; Gardin G; Jacomuzzi A; Monzeglio C
    Int J Cancer; 1987 Oct; 40(4):490-4. PubMed ID: 3666987
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytokinetic parameters of locally advanced human breast cancer treated with diethylstilbestrol and chemotherapy.
    Conte PF; Alama A; Di Marco E; Canavese G; Rosso R; Nicolin A
    Basic Appl Histochem; 1986; 30(2):227-31. PubMed ID: 3755591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.
    Conte PF; Pronzato P; Rubagotti A; Alama A; Amadori D; Demicheli R; Gardin G; Gentilini P; Jacomuzzi A; Lionetto R
    J Clin Oncol; 1987 Mar; 5(3):339-47. PubMed ID: 3546611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.